Monocyte CD36 Expression Predicts Disease Activity in Patients With Crohn’s Disease

Monocyte CD36 Expression Predicts Disease Activity in Patients With Crohn’s Disease

Conclusions: These data indicate that monocyte CD36 associates with disease activity in CD and might be a potential biomarker for assessing the activity of CD.

Saved in:

Bibliographic Details
Main Authors:	Jiejie Zhu, Nannan Zhu, Jiren Wang, Qiuyuan Liu, Qiao Mei
Format:	Article
Language:	English
Published:	Wiley 2024-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2024/9202686
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IL-36 signaling as a drug target in Crohn’s disease patients with IL36RN mutations
by: Julia Hecker, et al.
Published: (2025-05-01)

Monocyte-cancer cell fusion is mediated by phosphatidylserine-CD36 receptor interaction and induced by ionizing radiation.
by: Ivan Shabo, et al.
Published: (2025-01-01)

Machine learning gene expression predicting model for ustekinumab response in patients with Crohn's disease
by: Manrong He, et al.
Published: (2021-12-01)

Perianal Crohn’s Disease - an Active Approach
by: G Hellers
Published: (1993-01-01)

Profound gene expression changes in the epithelial monolayer of active ulcerative colitis and Crohn's disease.
by: Siri Sæterstad, et al.
Published: (2022-01-01)

Adipocytes regulate monocyte development through the OGT-NEFA-CD36/FABP4 pathway in high-fat diet-induced obesity
by: Na He, et al.
Published: (2025-05-01)

Usefulness of Endoscopic Indices in Determination of Disease Activity in Patients with Crohn’s Disease
by: Marcin Kucharski, et al.
Published: (2016-01-01)

Research progress in the surgical treatment of anorectal stricture in Crohn disease
by: Jin-Rong LI, et al.
Published: (2023-12-01)

Assessing CD36 and CD47 expression levels in solid tumor indications to stratify patients for VT1021 treatment
by: Suming Wang, et al.
Published: (2024-12-01)

Expression of CD80 and HLA-DR molecules on blood monocytes in patients with pulmonary tuberculosis
by: E. G. Churina, et al.
Published: (2021-11-01)

Predictive accuracy of fecal calprotectin in assessing clinical activity and disease severity in patients with Ulcerative Colitis and Crohn’s disease
by: Ankit V. Jain, et al.
Published: (2025-06-01)

Noninvasive Stool RNA Test Approximates Disease Activity in Patients With Crohn’s Disease
by: Ryan B. Ghannam, et al.
Published: (2024-01-01)

Correction: Profound gene expression changes in the epithelial monolayer of active ulcerative colitis and Crohn's disease.
by: Siri Sæterstad, et al.
Published: (2025-01-01)

The involvement of CD14 in the activation of human monocytes by peptidoglycan monomers
by: Damir Muhvic, et al.
Published: (2001-01-01)

Elevated Levels of IL-27 Are Associated with Disease Activity in Patients with Crohn’s Disease
by: Xiufang Cui, et al.
Published: (2021-01-01)

Activation of monocytes and early manifestations of cardiovascular diseases in patients with immuneinflammatory rheumatic diseases
by: M. V. Shalygina
Published: (2025-03-01)

Bibliometric analysis of Crohn's disease in children, 2014–2024
by: Yanjing Zhu, et al.
Published: (2025-03-01)

Crohn’s Disease and Cheilitis
by: Abdulrahman A Al-Hussaini, et al.
Published: (2003-01-01)

Immunotherapy of Crohn's disease
by: C. van Montfrans, et al.
Published: (1998-01-01)

Monocyte gene expression signature of patients with early onset coronary artery disease.
by: Suthesh Sivapalaratnam, et al.
Published: (2012-01-01)

Pro-inflammatory activation of monocytes in patients with immunoinflammatory rheumatic diseases
by: A. I. Bogatyreva, et al.
Published: (2024-01-01)

Pro-inflammatory activation of monocytes in patients with immunoinflammatory rheumatic diseases
by: E. V. Gerasimova, et al.
Published: (2024-07-01)

T-lymphocytes suppression by CD14+ monocytes with high expression of ULK2 in patients with multiple myeloma
by: Fengping Peng, et al.
Published: (2025-05-01)

IL-10 Treatment Is Associated with Prohibitin Expression in the Crohn’s Disease Intestinal Fibrosis Mouse Model
by: C. Yuan, et al.
Published: (2013-01-01)

Strategies and methods of medical therapy for refractory Crohn's disease
by: Qiao ZHONG, et al.
Published: (2022-10-01)

Serum Syndecan-1 Levels and Its Relationship to Disease Activity in Patients with Crohn’s Disease
by: Cem Çekiç, et al.
Published: (2015-01-01)

CD56 and Tim-3 molecule expression in different monocyte subsets in physiological pregnancy
by: E. G. Orlova, et al.
Published: (2023-06-01)

Case Report: Crohn’s disease with coexisting mesenteric schwannoma
by: Juntao Lu, et al.
Published: (2025-07-01)

Mass screening for CD36 antigen expression and analysis of negative donor structure and supply capacity
by: XU Yunping, et al.
Published: (2025-05-01)

Phenotype and functions of human dendritic cells derived from CD14+ monocyte subsets opposed to CD16 expression
by: E. R. Chernykh, et al.
Published: (2019-05-01)

Prominence of Microbiota to Predict Fibrous Stenosis in Crohn’s Disease
by: Yang X, et al.
Published: (2025-02-01)

Computed tomography enterography-based radiomics nomograms to predict inflammatory activity for ileocolonic Crohn’s disease: a preliminary single-center retrospective study
by: Yuping Ma, et al.
Published: (2025-01-01)

JAK Inhibitor and Crohn’s Disease
by: Mengyan Xu, et al.
Published: (2025-05-01)

Steroid-Dependent Crohn’s Disease
by: William J Sandborn
Published: (2000-01-01)

Gastroduodenal form of Crohn's disease
by: I. V. Mayev, et al.
Published: (2015-10-01)

DIAGNOSTIC IMAGING IN CROHN'S DISEASE
by: G.M. ZHARGALOVA, et al.
Published: (2025-07-01)

Infliximab in the Treatment of Crohn’s Disease
by: Brian Feagan
Published: (2000-01-01)

Appendiceal Carcinoids In Crohn’s Disease
by: Hugh J Freeman
Published: (2003-01-01)

New case of Crohn's disease
by: I. Y. Statsenko, et al.
Published: (2023-04-01)

Dietary Sugar and Crohn's Disease
by: K.W. Heaton
Published: (1988-01-01)